---

Top Highlights for August 2014: (Please click on read more to see details)

1. Venus Remedies of India ties up with Teva for anti-cancer drug 
2. $50 Billion revenue projected by 2025 for Indian medical technology industry from current $6.3 Billion: CII Report Read more
3. US-based Cancer Genetics acquires BioServe India for approximately $1.9 millionRead more
4. Bosch expands in India by launching eye screening and detection system
5. Promega, a $350 million Fitchburg company expands into Indian market Read more
6. India's Emcure, Sanofi enter into marketing & distribution pact for anti-rabies vaccine, Verorab. 
7. India based Lupin inks pact with South Korean firm to launch diabetes drug Insulin Glargine 
8. Roche signs deal with Emcure, India to make 2 anti-cancer biologic drugs Herceptin and MabThera 
9. Emcure enters into Agreement with BMS to acquire Oncology Product BiCNU 
10. GEN Top-25 biotech companies 2014 list includes India’s Sun Pharma & Dr. Reddy'sRead more
11. "India is an attractive market on all parameters": Edelweiss Read more

Aagami Updates: (Please click on hyperlink to view details)

1. Aagami Inc. attending BIO-Europe 2014 at Frankfurt, Germany Read more
2. Aagami's latest Company Presentation and Case Studies are available on its company website